Skip to main content

Table 4 Comparison between U/S results in the studied patients

From: Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)

N = 200 At the start of treatment After 1 month of treatment At the end of treatment p-value
Abdominal ultrasounds
 Normal 115 (57.5%) 115 (57.5%) 114 (57%) p1 = 1.0 NS
Fatty 57 (28.5%) 57 (28.5%) 58 (29%) p2 = 0.993NS
Cirrhotic 28 (14%) 28 (14%) 28 (14%) p3 = 0.993 NS
  1. X2: chi-square test
  2. S: p-value < 0.05 is considered significant
  3. HS: p-value < 0.001 is considered highly significant
  4. P1: refers to the statistical difference between the start of DAA and 1 month after DAA
  5. P2: refers to the statistical difference between the start of DAA and the end of DAA
  6. P3: refers to the statistical difference between 1 month after DAA and the end of DAA